It’s really important to take advantage of the data in an electronic health record (EHR) system, but sometimes people don’t know what information is being captured behind the scenes, said Pamela Tobias, MS, RHIA, CHDA, administrator of oncology services at Lehigh Valley Health Network.
It’s really important to take advantage of the data in an electronic health record (EHR) system, but sometimes people don’t know what information is being captured behind the scenes, said Pamela Tobias, MS, RHIA, CHDA, administrator of oncology services at Lehigh Valley Health Network.
Transcript
How can data from electronic health records be used to identify areas of improvement that can ultimately reduce costs?
One of the things that I think is really a powerful tool within EHRs, is some of the risk-scoring systems that they have. There are standardized tools that can look at things like risk for sepsis, risk for morbidity and mortality, risk for deep vein thrombosis. All of those let us intervene ahead of time, based on patient’s variables that something is impending rather than trying to respond to something that has actually happened. When we find things or can avoid things that’s certainly much less costly than trying to fix something that’s happened after the fact.
What sorts of inefficiencies might you find in hospitals that aren’t using their EHRs efficiently?
It’s really important to take advantage of the data that’s in your system. Looking at things like throughput, turnover, capacity, in addition to the quality and outcomes is really important. So, if you’re not utilizing it for those needs, then you’re missing an opportunity to make some great improvements. We’ve had the opportunity to utilize some data analytics as it relates to infusion throughput and capacity, and it’s been really eye opening—for as much as the Lean methodologies that we’ve tried to employ to make things better on our own, we truly needed the data analytics component to help us take things really to the next level and then ensure that they are hardwired into the process. And then keep an eye on it going forward.
What data in an EHR do you believe goes underutilized?
I think we’re most comfortable utilizing financial data from EHRs. I think we’re less comfortable utilizing the quality data because it’s harder to get at. We typically have to have a program or report writer to pull it out for us. I think sometimes we don’t know what information might be captured behind the scenes on throughput. Things like check in times, check out times, when a medication comes up or comes down, room turnover times. Some of that information is already in our EHRs and we just need to know to go after it.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More